OraSure Q1 FY26 net loss widens to $22.38 million; revenue drops 7% to $27.93 million
OraSure Technologies, Inc.
OraSure Technologies, Inc. OSUR | 0.00 |
- OraSure Technologies posted Q1 revenue of USD 27.9 million, down 7% year over year, while net loss widened to USD 22.4 million and diluted EPS fell to USD -0.32.
- Operating loss widened to USD 23.3 million as research and development expense climbed to USD 13.7 million.
- Gross margin improved 1.2 percentage points to 42.3%, with cash and cash equivalents at USD 177 million at March 31, 2026.
- Diagnostics revenue slipped 5% to USD 16.9 million due to lower revenue from HCV tests, while sample management solutions edged down 0.6% to USD 9.1 million.
- Guided to Q2 total revenue of USD 27 million to USD 30 million, citing gross margin expansion and plans to leverage manufacturing capacity for operating efficiencies as it approaches regulatory and commercial milestones in 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OraSure Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605061605PRIMZONEFULLFEED9714701) on May 06, 2026, and is solely responsible for the information contained therein.
